Filter
4146
Text search:
hiv
drugs
Featured
Recommendations
361
New Publications
1137
Language
Document type
No document type
2764
Guidelines
488
Studies & Reports
472
Manuals
141
Strategic & Response Plan
104
Training Material
65
Fact sheets
57
Situation Updates
25
Infographics
18
Resource Platforms
5
Brochures
4
Online Courses
2
Countries / Regions
India
227
Kenya
158
South Africa
125
Global
101
Uganda
100
Ethiopia
98
Nigeria
97
Zambia
95
Tanzania
91
Nepal
89
Malawi
87
Western and Central Europe
71
Sierra Leone
67
Rwanda
67
Liberia
61
Africa
56
Bangladesh
55
Ghana
54
Namibia
51
Myanmar / Burma
50
Ukraine
49
Eastern Europe
48
Latin America and the Carribbean
40
Asia
40
Zimbabwe
38
Philippines
38
Indonesia
37
Lesotho
37
Cambodia
30
Mozambique
29
Russia
27
Congo, Democratic Republic of
26
Senegal
25
Botswana
25
Burkina Faso
23
Eswatini/ Swaziland
21
South–East Asia Region
20
Colombia
15
Tajikistan
15
Cameroon
14
Germany
13
Venezuela
13
Haiti
12
Albania
12
East and Southern Africa
11
Argentina
10
Brazil
10
Georgia
10
Pakistan
9
South Sudan
8
Benin
8
Eastern Europe and Central Asia
8
Moldova
8
Guinea
7
North Macedonia
7
Middle East and North Africa
7
Syria
6
Thailand
6
Sudan
6
Vietnam
6
Somalia
5
Afghanistan
5
West and Central Africa
5
Armenia
5
Laos
5
Jordan
4
Lebanon
4
Central African Republic
4
Southern Africa
4
Estonia
4
Mali
3
Peru
3
Hungary
3
Burundi
3
Sri Lanka
3
Yemen
3
Western Pacific Region
3
Paraguay
3
Bhutan
3
Timor Leste/ East Timor
3
Romania
3
Iran
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Iraq
2
Chad
2
China
2
Papua New Guinea
2
Serbia
2
Bolivia
2
Angola
2
Madagascar
2
Poland
2
Qatar
2
Uzbekistan
2
North America
2
Guinea-Bissau
1
USA
1
Niger
1
Turkey
1
Egypt
1
Gambia
1
Singapore
1
Switzerland
1
Ecuador
1
El Salvador
1
Greece
1
Libya
1
Mexico
1
Chile
1
Solomon Islands
1
Palestine
1
North Korea
1
Djibouti
1
Canada
1
Bulgaria
1
Kyrgyzstan
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
1759
Clinical Guidelines
352
Women & Child Health
201
Public Health
130
Key Resources
106
Capacity Building
84
Pharmacy & Technologies
35
Annual Report MEDBOX
1
Toolboxes
HIV
822
TB
480
Mental Health
202
AMR
116
COVID-19
113
Caregiver
96
Pharmacy
91
NTDs
76
Refugee
54
Disability
44
Ebola & Marburg
42
Conflict
39
Global Health Education
39
NCDs
37
Malaria
36
Health Financing Toolbox
35
Planetary Health
25
Rapid Response
23
Natural Hazards
22
Polio
16
Cholera
11
Zika
7
Social Ethics
7
2.0 Rapid Response
6
Specific Hazards
2
South Sudan
1
People Who Inject Drugs
In addition, the following individuals of our external expert advisory committee made instrumental contributions to the initial design and content of the document: Billy Pick, USAID; Daniel Wolfe, Open Society Foundations;
...
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antire
...
The uneven distribution of HIV risks and burdens across populations is a well-substantiated fact, though seldom publicly acknowledged. Gay men and other men who have sex with men, people who inject drugs
...
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and innovation in new drugs and diagnostics. Key approache
...
During ARV drug pressure the HIV-1 RT is able to develop resistance to these drugs by generating mutations
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention
...
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnos ...
• diagnos ...
These guidelines, produced in 2022 by the Uganda Ministry of Health, provide guidance on the diagnosis of HIV, the care of people living with HIV, and the use of antiretroviral
...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers
...
Countries experiencing concentrated epidemics of HIV need the size of key populations (KPs) to guide the national response on HIV and AIDS. Conducting a robust method to estimate the size of KPs is
...
Malaria and HIV, two of the world’s most deadly diseases, are widespread, but their distribution overlaps greatly in sub-Saharan Africa. Consequently, malaria and HIV coinfection (MHC) is common i
...
Alternative Thematic Report on implementation of the Convention on Elimination of all Forms of discrimination against Women on the issues related to women living with HIV from the affected groups (women – former prisoners, women using injected
...
Decree of the Minister of Health of the Republic of Indonesia Number 1190 / MENKES / SK / X / 2004 on the Free Drug of Anti Tuberculosis (OAT) and Anti Retro Viral (ARV) Drugs for HIV / AIDS
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies
...
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative c
...
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen and liver enlargement, and, if not treated, death. P
...